400837-92-5

Basic information

• Product Name: Ethanol, 2-[(4-bromophenyl)methoxy]-
• Synonyms: 2-(4-Brom-benzyloxy)-aethanol;2-(4-bromo-benzyloxy)-ethanol;Ethanol,2-[(4-bromophenyl)methoxy];(2-Hydroxy-aethyl)-(4-brom-benzyl)-aether;2-{[(4-bromophenyl)methyl]oxy}ethanol;2-Hydroxy-1-(4-brom-benzyloxy)-aethan
• CAS NO: 400837-92-5
• Molecular Formula: C9H11BrO2
• Molecular Weight: 231.089
• Mol File: 400837-92-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Ethanol, 2-[(4-bromophenyl)methoxy]-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanol, 2-[(4-bromophenyl)methoxy]-(400837-92-5)
• EPA Substance Registry System: Ethanol, 2-[(4-bromophenyl)methoxy]-(400837-92-5)

Safety Data

• Hazardous Substances Data: 400837-92-5(Hazardous Substances Data)

Upstream product

• 107-21-1 ethylene glycol 
• 589-15-1 1-bromomethyl-4-bromobenzene 

Downstream Products

• 82157-28-6 (4-bromo-benzyl)-(2-chloro-ethyl)-ether 
• 103061-55-8 1-bromo-4-{[(2-bromoethyl)oxy]methyl}benzene 
• 434308-95-9 [(1S,2S)-1-(4-Bromo-benzyloxymethyl)-2-methyl-but-3-enyl]-[1-(4-methoxy-phenyl)-meth-(E)-ylidene]-amine 
• 434308-80-2 C₃₄H₅₃BrN₄O₇Si 
• 434309-04-3 (3R,4aS,6S,7R,8S)-8-(4-Bromo-benzyloxymethyl)-3-[(S)-(tert-butyl-dimethyl-silanyloxy)-(2,6-dimethoxy-pyrimidin-4-yl)-methyl]-6-hydroxy-7-methyl-octahydro-pyrido[1,2-c]pyrimidin-1-one 
• 434309-02-1 (3R,4aS,7R,8S)-8-(4-Bromo-benzyloxymethyl)-3-[(S)-(tert-butyl-dimethyl-silanyloxy)-(2,6-dimethoxy-pyrimidin-4-yl)-methyl]-7-methyl-hexahydro-pyrido[1,2-c]pyrimidine-1,6-dione 
• 434308-66-4 2-[(1S,2S)-1-(4-Bromo-benzyloxymethyl)-2-methyl-but-3-enyl]-3-(4-methoxy-phenyl)-oxaziridine 
• 434308-62-0 (3S,4R)-5-(4-bromobenzyloxy)-4-(methanesulfonyloxy)-3-methylpent-1-ene 
• 434308-56-2 (3S,4S)-5-(4-bromobenzyloxy)-4-hydroxylamino-3-methylpent-1-ene 

Relevant articles and documents

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ENHANCER OF ZESTE HOMOLOG 2 POLYPEPTIDE

The present disclosure relates to bifunctional compounds, which find utility as modulators of enhancer of zeste homolog 2 (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a Von Hippel-Lindau, cereblon, Inhibitors of Apotosis Proteins or mouse double-minute homolog 2 ligand which binds to the respective E3 ubiquitin ligase and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

Muscarinic acetylcholine receptor antagonists

Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.

Asymmetric synthesis of epicylindrospermopsin via intramolecular nitrone cycloaddition. Assignment of absolute configuration

A synthesis of (-)-epicylindrospermopsin (2) was completed that establishes its absolute configuration and corroborates the corrected structural assignment previously made to this toxin by Weinreb et al. The hydroxylamine 3, prepared from 4-bromobenzyloxy